cost and efficacy an update stephen curtin m d bone marrow
play

Cost and Efficacy: an Update Stephen Curtin M.D. Bone marrow - PowerPoint PPT Presentation

Cost and Efficacy: an Update Stephen Curtin M.D. Bone marrow Simple aspirate added to various synthetic bone Platelets Platelet Gel Platelet Rich Plasma Mesenchymal Stem Cells Osteoprogenitor Cells Cost


  1. Cost and Efficacy: an Update Stephen Curtin M.D.

  2. Bone marrow • • Simple aspirate added to various “synthetic bone” Platelets • • Platelet Gel • Platelet Rich Plasma Mesenchymal Stem Cells • • Osteoprogenitor Cells

  3. • Cost is in the Needle • Simple can be aspirated from crest or pedicle • Typically added to allomatrix and DBM as an Extender • Ineffective as a Stand alone in combination with collagen- hydroxyapatite sponge

  4. NovaBone : Calcium Phosphosilicate • Vitoss: “Porous” Calcium Phosphate and • Bioactive glass ProOsteon: HA CaCO2 &CaPO4 • Norian: CaPO4 • MasterGraft: HA & B -TCP •

  5. Autologous Growth Bone substitutes and • • expanders in Spine Surgery: A Factors review of their fusion • PDGF, TGF- B efficacies Int J Spine Surg. 2016; 10: 33 . Platelet Gel • Abhijeet Kadam, MD,corresponding author1 Paul W Millhouse, MD,2 Christopher K Kepler, MD, MBA,2 Platelet Rich Plasma Kris E. Radcliff, MD,2 Michael G. Fehlings, MD, PhD, • FRCSC,3 Michael E. Janssen, DO,4 Rick C. Sasso, Literature is mixed MD,5 James J. Benedict, PhD, MD,6 and Alexander R Vaccaro, MD, PhD, MBA2 • Bone Graft and Bone Graft Not recommended nor • • Substitutes in Spine Surgery: supported at this time Current Concepts and in spine surgery Controversies JAAOS - Journal of the American Academy of Orthopaedic Surgeons: January 2013 - Volume 21 - Issue 1 – p51- 60 Grabowski, Gregory MD; Cornett, Chris A. MD

  6. Requires • Preparation/Centrifuge Generally not covered • by insurance No controlled clinical • trials $5000 Back Pain • treatment

  7. Currently commercial • products are allograft Limited Data • More Evidence is • Needed Autogenous Banking • in the Future?

  8. Marrow Aspirate: theoretical advantage as an • adjunct, not stand alone, low cost Platelets and PRP: No data or contradictory • data, high cost Mesenchymal Progenitor Cells: Auto sources • are futuristic, costly, current Allo souces lack data

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend